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Associations between parent or caregiver depression and
adverse child outcomes are well established.1 We pre-
viously examined correlations of symptoms of common
mental disorders in caregivers with offspring psycho-
pathology in a Brazilian sample.2 Sixty-eight primary
caregivers of 110 children (age 6-15 years) were enrolled.
Caregivers were assessed using the Self-Reporting
Questionnaire3 (SRQ-20), which measures symptoms of
common mental disorders. We used the Strengths and
Difficulties Questionnaire (SDQ) to measure children’s
symptoms. In our previous results, higher SRQ-20 scores
in caregivers correlated significantly with offspring psy-
chiatric symptoms (beta = 0.20; p = 0.04).
We further investigated this result by conducting a
discriminant analysis. A multinomial logistic regression with
Bayesian estimation (Mplus, 7.4) was carried out to identify
the symptoms assessed with the SRQ-20, discriminat-
ing three groups of children: 1) asymptomatic (SDQo 14,
impact supplement score = 0); 2) symptomatic without
impact (SDQ X 14, impact supplement score = 0); and
3) symptomatic with impact (SDQ X 14, impact supple-
ment score X 1).
The results (Table 1) showed that caregivers of symp-
tomatic children without impact reported lower depressed
mood, lower somatic (anxiety) and somatic (gastrointest-
inal) symptoms, more weight loss, and lower insight com-
pared to caregivers of asymptomatic children. Caregivers
of symptomatic children with impact reported lower depres-
sed mood, lower retardation, more agitation, lower somatic
(gastrointestinal) symptoms, more weight loss, and less
insight than caregivers of asymptomatic children. Compar-
ison between the two groups of caregivers of symptomatic
children showed that the group with impact reported higher
levels of early insomnia, lower retardation, lower agitation,
higher anxiety (psychological and somatic), more somatic
symptoms, and less insight.
These results possibly demonstrate a trend toward
symptomatology interaction between caregivers and their
offspring. Weissman et al. studied the differential effects
of a depressed mother’s treatment on her child, and found
that children whose mothers were on escitalopram showed
significantly greater improvement in symptoms and func-
tioning as compared to children whose mothers were on
bupropion or a combination of both.4 The authors also
observed that maternal baseline negative affectivity (which
captures high levels of stress, irritability, and anxiety)
appeared to moderate the effect of maternal treatment on
children. Possibly, these mothers are better treated with
escitalopram, which enhances serotoninergic neurotrans-
mission, as compared to bupropion, which enhances dopa-
minergic transmission.
In another study, Morgan et al. evaluated how maternal
neural response to child affect is related to depression by
using an fMRI task.5 They found that comorbid anxiety,
chronicity of depression, and poor mother-child relationship
emerged as predictors of altered maternal neural response
to child affect. Few studies have sought to elucidate the
mechanisms of parental-offspring psychopathology.
Table 1 Results of multinomial logistic Bayesian regression analysis
SDQ- vs. SDQ+
without impact
SDQ- vs. SDQ+
with impact
SDQ+ without impact vs.
SDQ+ with impact
Beta p-value Beta p-value Beta p-value
Depressed mood -0.25 0.04 -0.32 0.03 -0.18 0.11
Feelings of guilt 0.25 0.09 0.18 0.09 0.20 0.06
Suicide -0.19 0.15 -0.13 0.17 0.21 0.07
Insomnia, early -0.30 0.09 0.09 0.32 0.46 0.00
Insomnia, middle 0.38 0.06 0.01 0.48 -0.08 0.30
Insomnia, late -0.13 0.32 0.01 0.50 -0.15 0.19
Work and activities 0.04 0.43 0.07 0.34 -0.08 0.31
Retardation, psychomotor 0.01 0.47 -0.34 0.02 -0.22 0.03
Agitation 0.28 0.08 0.44 0.01 -0.40 0.01
Anxiety (psychological) 0.20 0.15 0.24 0.06 0.40 0.01
Anxiety (somatic) -0.32 0.02 -0.13 0.21 0.32 0.01
Somatic symptoms (gastrointestinal) -0.54 0.01 -0.40 0.03 0.27 0.09
Somatic symptoms (general) -0.06 0.34 -0.04 0.38 0.27 0.01
Genital symptoms -0.00 0.50 -0.08 0.30 -0.19 0.07
Hypochondriasis 0.07 0.35 0.00 0.50 -0.18 0.08
Weight loss 0.54 0.00 0.53 0.01 -0.21 0.09
Insight -0.34 0.00 -0.26 0.02 0.20 0.04
SDQ = Strengths and Difficulties Questionnaire applied to children; SRQ-20 = Self Reporting Questionnaire-20 applied to adult caregivers;
SDQ- = asymptomatic children (SDQ o 14); SDQ+ = symptomatic children (SDQ X 14); impact = symptomatic children with impact
supplement score X 1.
Bold font indicates statistical significance.
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Despite the role of anxiety in these previous studies, in
our analysis, we found that agitation, less retardation, less
depressed mood, less somatic symptoms, and more weight
loss seem to characterize the caregivers of symptomatic
versus asymptomatic children. When comparing only care-
givers of symptomatic children, those caring for children
with impact presented higher levels of anxiety, which is
in line with the existing literature. Greater knowledge of
mechanisms underlying caregiver-offspring interactions
is needed to improve treatment strategies.
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The prevalence of mental disorders is high among pre-
gnant women.1 Major depression during pregnancy is a
risk factor for negative outcomes for both mother and
child.2 Psychotherapy and pharmacotherapy are well-
established conventional treatments for depression.
However, some cases fail to respond, and the safety of
some psychopharmaceuticals during pregnancy is unclear.
Within this context, certain neuromodulation techniques,
including repetitive transcranial magnetic stimulation (rTMS),
have been studied in pregnant women with depression.
A review of the recent literature3 suggested that rTMS
is an effective alternative for the treatment of depression
in pregnant women, and there have been no reports of
malformations or other relevant negative fetal outcomes.4
However, use of the rTMS technique in pregnant women
has only been evaluated in one open study5 and a few
case reports; there have been no randomized clinical
trials evaluating its use in this setting. Here, we report the
cases of four nulliparous pregnant women (one with a twin
pregnancy) diagnosed with major depressive disorder and
treated with rTMS.
Sociodemographic and clinical features are summarized
in Table 1. In three patients, rTMS was applied to the left
dorsolateral prefrontal cortex (DLPFC) at 3,000 pulses/
session (120% of the motor threshold; frequency 10 Hz;
figure-eight coil). In the remaining patient, rTMS was applied
to the right DLPFC at 1,800 pulses/session (120% of the
motor threshold; frequency 1 Hz; figure-eight coil). To eval-
uate symptoms of depression and anxiety, the 21-item
Hamilton Depression Rating Scale (HDRS-21), the 14-item
Hamilton Anxiety Rating Scale (HARS-14), and the Clinical
Global Impression-Severity (CGI-S) scale were applied
before and after rTMS. Three of the patients were medicated,
two with sertraline and one with fluoxetine, and the prescri-
bed dosages were maintained throughout rTMS treatment.
According to the HDRS-21 and HARS-14, all patients
presented a response, with a 65% mean reduction in
depressive and anxiety symptoms. CGI-S scores also
showed a 66% reduction in depressive symptoms. All
patients tolerated the treatment, although all but one reported
some side effects. None of the patients had complications at
delivery. All infants had 5-minute Apgar scores of 9, except
for the twins born to patient 2, who were preterm (36
weeks) and had Apgar scores of 6 and 8.
Our results are in agreement with existing experience
regarding the responses obtained with rTMS in pregnant
women with depression. Our choice of the prefrontal cor-
tex as the rTMS target was based on previous reports.5,6
The frequency of stimulation varies according to the side
of application. Studies of rTMS in pregnant women with
depression have employed 10-25 Hz and 1 Hz in the left
and right DLPFC, respectively, quite similar to the fre-
quencies used in the general population of adults with
depression.2 Despite these promising findings, there is a
need for controlled, double-blind studies involving larger
samples, with well-designed rTMS parameters, and even
for prospective studies (following pregnant women and
their offspring) to assess the long-term safety of rTMS in
children exposed in utero.
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